Bantam Pharmaceuticals
Clinical trials sponsored by Bantam Pharmaceuticals, explained in plain language.
-
New cancer drug BTM-3566 enters human testing for advanced tumors
Disease control Recruiting nowThis early-phase trial tests the safety and best dose of a new drug called BTM-3566 in 30 adults with advanced solid tumors that have not responded to standard treatments. Participants take the drug for 7 days, then pause for 7 days, repeating until the cancer worsens or side eff…
Phase: PHASE1 • Sponsor: Bantam Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New drug BTM-3566 aims to fight Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-stage trial tests a new drug called BTM-3566 in 24 adults whose B-cell lymphoma has returned or stopped responding to treatment. The main goals are to check the drug's safety, find the right dose, and see if it can slow or stop the cancer. Participants take the drug in…
Phase: PHASE1 • Sponsor: Bantam Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 12:06 UTC